Stein WD - Search Results

1

Low and high concentrations of the topo II inhibitor daunorubicin in NIH3T3 cells: reversible G2/M versus irreversible G1 and S arrest.

Stein WD, Robey R, Cardarelli C, Gottesman MM, Bates SE. Stein WD, et al. Cell Cycle. 2003 Mar-Apr;2(2):134-42. Cell Cycle. 2003. PMID: 12695665

2

Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin.

Luchenko VL, Litman T, Chakraborty AR, Heffner A, Devor C, Wilkerson J, Stein W, Robey RW, Bangiolo L, Levens D, Bates SE. Luchenko VL, et al. Mol Oncol. 2014 Dec;8(8):1379-92. doi: 10.1016/j.molonc.2014.05.001. Epub 2014 May 28. Mol Oncol. 2014. PMID: 24954856 Free PMC article.

3

A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins.

Stein WD, Litman T, Fojo T, Bates SE. Stein WD, et al. Cancer Res. 2004 Apr 15;64(8):2805-16. doi: 10.1158/0008-5472.can-03-3383. Cancer Res. 2004. PMID: 15087397

4

Therapies with diverse mechanisms of action kill cells by a similar exponential process in advanced cancers.

Blagoev KB, Wilkerson J, Stein WD, Yang J, Bates SE, Fojo T. Blagoev KB, et al. Among authors: stein wd. Cancer Res. 2014 Sep 1;74(17):4653-62. doi: 10.1158/0008-5472.CAN-14-0420. Cancer Res. 2014. PMID: 25183789 Free PMC article.

5

Intractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attack.

Stein WD, Bates SE, Fojo T. Stein WD, et al. Curr Drug Targets. 2004 May;5(4):333-46. doi: 10.2174/1389450043345489. Curr Drug Targets. 2004. PMID: 15134216 Review.

6

Differential expression of cell adhesion genes: implications for drug resistance.

Stein WD, Litman T, Fojo T, Bates SE. Stein WD, et al. Int J Cancer. 2005 Mar 1;113(6):861-5. doi: 10.1002/ijc.20671. Int J Cancer. 2005. PMID: 15514970 Review.

7

Continuing a cancer treatment despite tumor growth may be valuable: sunitinib in renal cell carcinoma as example.

Burotto M, Wilkerson J, Stein W, Motzer R, Bates S, Fojo T. Burotto M, et al. PLoS One. 2014 May 5;9(5):e96316. doi: 10.1371/journal.pone.0096316. eCollection 2014. PLoS One. 2014. PMID: 24796484 Free PMC article. Clinical Trial.

8

A database study that identifies genes whose expression correlates, negatively or positively, with 5-year survival of cancer patients.

Stein WD, Litman T, Fojo T, Bates SE. Stein WD, et al. Biochim Biophys Acta. 2007 Jun;1770(6):857-71. doi: 10.1016/j.bbagen.2006.12.013. Epub 2007 Jan 25. Biochim Biophys Acta. 2007. PMID: 17398010

9

PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumors.

Steadman K, Stein WD, Litman T, Yang SX, Abu-Asab M, Dutcher SK, Bates S. Steadman K, et al. Among authors: stein wd. Cell Cycle. 2008 Mar 15;7(6):818-29. doi: 10.4161/cc.7.6.5597. Epub 2008 Jan 9. Cell Cycle. 2008. PMID: 18239467

10

Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis.

Wilkerson J, Abdallah K, Hugh-Jones C, Curt G, Rothenberg M, Simantov R, Murphy M, Morrell J, Beetsch J, Sargent DJ, Scher HI, Lebowitz P, Simon R, Stein WD, Bates SE, Fojo T. Wilkerson J, et al. Among authors: stein wd. Lancet Oncol. 2017 Jan;18(1):143-154. doi: 10.1016/S1470-2045(16)30633-7. Epub 2016 Dec 13. Lancet Oncol. 2017. PMID: 27979599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters